Purchases and Sales Made in Q1 2023 in Ngm Biopharmaceuticals Inc (NGM)
This table provides information about the institutional ownership of Ngm Biopharmaceuticals Inc (NGM) during Q1 2023. The information is specifically focused on institutions that hold shares of NGM BIOPHARMACEUTICALS INC.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 11, 2023
Q1 2023
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-57.6K- 10.18% |
$214K - $311K
|
509K
$0
|
|
|
May 15, 2023
Q1 2023
|
Cubist Systematic Strategies, LLC
Stamford, CT |
SELL
|
- |
-71.2K- 51.23% |
$265K - $385K
|
67.8K
$0
|
|
|
May 15, 2023
Q1 2023
|
Graham Capital Management, L.P.
Rowayton, CT |
SELL
|
- |
-80.1K- 71.06% |
$298K - $433K
|
32.6K
$0
|
|
|
May 12, 2023
Q1 2023
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-84K- 15.33% |
$312K - $453K
|
464K
$0
|
|
|
May 11, 2023
Q1 2023
|
Panagora Asset Management Inc
Boston, MA |
SELL
|
- |
-126K- 80.97% |
$470K - $682K
|
29.7K
$0
|
|
|
May 14, 2024
Q1 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-189K- 49.74% |
$703K - $1.02M
|
191K
$0
|
|
|
May 11, 2023
Q1 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-189K- 49.74% |
$703K - $1.02M
|
191K
$0
|
|
|
May 12, 2023
Q1 2023
|
Candriam S.C.A.
|
SELL
|
- |
-224K- 59.54% |
$833K - $1.21M
|
152K
$0
|
|
|
May 15, 2023
Q1 2023
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-811K- 18.06% |
$3.02M - $4.38M
|
3.68M
$0
|